Expression of the pituitary stem/progenitor marker GFRα2 in human pituitary adenomas and normal pituitary

Pituitary

Volumn 18, Issue 1, 2015, Pages 31-41

  Mathioudakis, Nestoras ^a   Sundaresh, Ram ^a   Larsen, Alexandra ^a   Ruff, William ^a   Schiller, Jennifer ^a   Guerrero Cázares, Hugo ^a   Burger, Peter ^a   Salvatori, Roberto ^a   Quiñones Hinojosa, Alfredo ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenoma; GFR 2; Glial cell line derived neurotrophic factor receptor alpha 2; Gonadotropinoma; Progenitor; Stem

Indexed keywords

COMPLEMENTARY DNA; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR ALPHA1; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR ALPHA2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR ALPHA3; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR ALPHA4; MESSENGER RNA; UNCLASSIFIED DRUG; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ACTH SECRETING CELL; ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FUNCTIONING PITUITARY ADENOMA; GENE EXPRESSION; GONADOTROPH ADENOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHYSIS; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NONFUNCTIONING PITUITARY ADENOMA; PITUITARY STEM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RATHKE CLEFT CYST; RATHKE REMNANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; STEM CELL NICHE; WESTERN BLOTTING; YOUNG ADULT; ADENOMA; GENE EXPRESSION REGULATION; GENETICS; HYPOPHYSIS TUMOR; METABOLISM; PATHOPHYSIOLOGY;

ADENOMA; ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PITUITARY GLAND; PITUITARY NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84931955459     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-014-0553-1     Document Type: Article

References (38)

1. Castinetti F, Davis SW, Brue T, Camper SA (2011) Pituitary stem cell update and potential implications for treating hypopituitarism. Endocr Rev 32(4):453–471. doi:10.1210/er.2010-0011
2. Florio T (2011) Adult pituitary stem cells: from pituitary plasticity to adenoma development. Neuroendocrinology 94(4):265–277
3. Rostad S (2012) Pituitary adenoma pathogenesis: an update. Curr Opin Endocrinol Diabetes Obes 19(4):322–327. doi:10.1097/MED.0b013e328354b2e2
4. Gaston-Massuet C, Andoniadou CL, Signore M, Jayakody SA, Charolidi N, Kyeyune R, Vernay B, Jacques TS, Taketo MM, Le Tissier P, Dattani MT, Martinez-Barbera JP (2011) Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. Proc Natl Acad Sci USA 108(28):11482–11487
5. Hosoyama T, Nishijo K, Garcia MM, Schaffer BS, Ohshima-Hosoyama S, Prajapati SI, Davis MD, Grant WF, Scheithauer BW, Marks DL, Rubin BP, Keller C (2010) A postnatal Pax7 progenitor gives rise to pituitary adenomas. Genes Cancer 1(4):388–402
6. Xu Q, Yuan X, Tunici P, Liu G, Fan X, Xu M, Hu J, Hwang JY, Farkas DL, Black KL, Yu JS (2009) Isolation of tumour stem-like cells from benign tumours. Br J Cancer 101(2):303–311
7. Garcia-Lavandeira M, Quereda V, Flores I, Saez C, Diaz-Rodriguez E, Japon MA, Ryan AK, Blasco MA, Dieguez C, Malumbres M, Alvarez CV (2009) A GRFa2/Prop1/stem (GPS) cell niche in the pituitary. PLoS One 4(3):e4815
8. Airaksinen MS, Saarma M (2002) The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3(5):383–394
9. Japon MA, Urbano AG, Saez C, Segura DI, Cerro AL, Dieguez C, Alvarez CV (2002) Glial-derived neurotropic factor and RET gene expression in normal human anterior pituitary cell types and in pituitary tumors. J Clin Endocrinol Metab 87(4):1879–1884
10. Garcia-Lavandeira M, Saez C, Diaz-Rodriguez E, Perez-Romero S, Senra A, Dieguez C, Japon MA, Alvarez CV (2012) Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors. J Clin Endocrinol Metab 97(1):E80–E87
11. Mete O, Asa SL (2012) Clinicopathological correlations in pituitary adenomas. Brain Pathol 22(4):443–453. doi:10.1111/j.1750-3639.2012.00599.x
12. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93(5):1526–1540. doi:10.1210/jc.2008-0125
13. Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler GB Jr (1994) A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 78(2):418–422
14. Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK (2011) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly—2011 update. Endocr Pract 17(Suppl 4):1–44
15. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA (2011) Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(2):273–288. doi:10.1210/jc.2010-1692
16. Greenman Y, Stern N (2009) Non-functioning pituitary adenomas. Best Pract Res Clin Endocrinol Metab 23(5):625–638
17. Asa SL (2011) Tumors of the pituitary gland, vol 15, 4 edn. AFIP Atlas of tumor pathology. American Registry of Pathology, Washington
18. DeLellis RA, Lloyd RV, Heitz PU, Eng C (2004) 2004 World Health Organization classification of tumours: Tumours of endocrine organs. IARC, Lyons
19. Oliveira VC, Carrara RC, Simoes DL, Saggioro FP, Carlotti CG Jr, Covas DT, Neder L (2010) Sudan Black B treatment reduces autofluorescence and improves resolution of in situ hybridization specific fluorescent signals of brain sections. Histol Histopathol 25(8):1017–1024
20. Lepore DA, Roeszler K, Wagner J, Ross SA, Bauer K, Thomas PQ (2005) Identification and enrichment of colony-forming cells from the adult murine pituitary. Exp Cell Res 308(1):166–176
21. Guerrero-Cazares H, Attenello FJ, Noiman L, Quinones-Hinojosa A (2012) Stem cells in gliomas. Handb Clin Neurol 104:63–73. doi:10.1016/B978-0-444-52138-5.00006-2
22. Hsu W, Mohyeldin A, Shah SR, Gokaslan ZL, Quinones-Hinojosa A (2012) Role of cancer stem cells in spine tumors: review of current literature. Neurosurgery 71(1):117–125. doi:10.1227/NEU.0b013e3182532e71
23. Chesler DA, Berger MS, Quinones-Hinojosa A (2012) The potential origin of glioblastoma initiating cells. Front Biosci (Schol Ed) 4:190–205
24. Chen K, Huang YH, Chen JL (2013) Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacol Sin. doi:10.1038/aps.2013.27
25. Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC, Dattani MT (2009) Genetic regulation of pituitary gland development in human and mouse. Endocr Rev 30(7):790–829. doi:10.1210/er.2009-0008
26. Kordek R, Potemski P, Kusinska R, Pluciennik E, Bednarek A (2010) Basal keratin expression in breast cancer by quantification of mRNA and by immunohistochemistry. J Exp Clin Cancer Res 29:39. doi:10.1186/1756-9966-29-39
27. Nordengren J, Casslen B, Gustavsson B, Einarsdottir M, Willen R (1998) Discordant expression of mRNA and protein for urokinase and tissue plasminogen activators (u-PA, t-PA) in endometrial carcinoma. Int J Cancer 79(2):195–201
28. Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, Kardia SL, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG (2002) Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 1(4):304–313
29. Pascal LE, True LD, Campbell DS, Deutsch EW, Risk M, Coleman IM, Eichner LJ, Nelson PS, Liu AY (2008) Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate. BMC Genom 9:246. doi:10.1186/1471-2164-9-246
30. Osamura RY, Kajiya H, Takei M, Egashira N, Tobita M, Takekoshi S, Teramoto A (2008) Pathology of the human pituitary adenomas. Histochem Cell Biol 130(3):495–507. doi:10.1007/s00418-008-0472-1
31. Asa SL, Ezzat S (1998) The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19(6):798–827
32. Pulichino AM, Vallette-Kasic S, Tsai JP, Couture C, Gauthier Y, Drouin J (2003) Tpit determines alternate fates during pituitary cell differentiation. Genes Dev 17(6):738–747. doi:10.1101/gad.1065703
33. Drouin J (2012) Pituitary development. In: Melmed S (ed) The pituitary. Academic Press, London
34. Nolan LA, Levy A (2006) A population of non-luteinising hormone/non-adrenocorticotrophic hormone-positive cells in the male rat anterior pituitary responds mitotically to both gonadectomy and adrenalectomy. J Neuroendocrinol 18(9):655–661. doi:10.1111/j.1365-2826.2006.01459.x
35. Vankelecom H, Chen J (2013) Pituitary stem cells: Where do we stand? Mol Cell Endocrinol. doi:10.1016/j.mce.2013.08.018
36. Dubois PM, el Amraoui A, Heritier AG (1997) Development and differentiation of pituitary cells. Microsc Res Tech 39(2):98–113. doi:10.1002/(SICI)1097-0029(19971015)39:2<98:AID-JEMT2>3.0.CO;2-S
37. Mollard P, Hodson DJ, Lafont C, Rizzoti K, Drouin J (2012) A tridimensional view of pituitary development and function. Trends Endocrinol Metab 23(6):261–269. doi:10.1016/j.tem.2012.02.004
38. Cooper O, Ben-Shlomo A, Bonert V, Bannykh S, Mirocha J, Melmed S (2010) Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes. Horm Cancer 1(2):80–92. doi:10.1007/s12672-010-0014-x